skip to main content

Valproate pregnancy prevention — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardCNS TherapeuticsValproate pregnancy preventionGPhC CRA

A 29-year-old woman taking sodium valproate modified-release 500mg twice daily asks for advice because she is planning pregnancy within a year. Her repeat prescription has no specialist letter attached. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: ADo not stop valproate suddenly and arrange urgent specialist review about pregnancy risks

Valproate is highly teratogenic and subject to strict pregnancy prevention requirements, but abrupt withdrawal can precipitate seizures. A woman planning pregnancy needs urgent specialist review to consider alternatives and risk minimisation. Pharmacists should ensure the patient understands the Patient Guide and contraception requirements where applicable. The medication should not be stopped or switched at the counter.

Reference: BNF; MHRA Drug Safety Update